These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2964165

  • 1. Clinical studies with a new, low-dose oral contraceptive combination, containing 0.150 mg desogestrel and 0.020 mg ethinylestradiol.
    Acta Obstet Gynecol Scand Suppl; 1987; 144():1-44. PubMed ID: 2964165
    [No Abstract] [Full Text] [Related]

  • 2. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence.
    Venturoli S, Porcu E, Gammi L, Fabbri R, Paradisi R, Flamigni C, Patrono D, Capelli M, Paoletti C.
    Acta Eur Fertil; 1988; 19(3):129-34. PubMed ID: 2976224
    [Abstract] [Full Text] [Related]

  • 3. Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.
    Rechberger T, Tomaszewski J, Pieprzowska-Białek A, Kulik-Rechberger B, Skorupski P.
    Contraception; 2004 Jun; 69(6):477-80. PubMed ID: 15157792
    [Abstract] [Full Text] [Related]

  • 4. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
    Weijers MJ.
    Fortschr Med; 1982 Apr 29; 100(16):764-7. PubMed ID: 6211403
    [Abstract] [Full Text] [Related]

  • 5. [Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].
    Cremer P, Vekemans M.
    Rev Med Brux; 1987 Nov 29; 8(9):440-6. PubMed ID: 3423522
    [No Abstract] [Full Text] [Related]

  • 6. Development of an oral contraceptive containing a new progestogen, desogestrel, and 30 micrograms ethinylestradiol. Report on clinical studies from Scandinavia.
    Acta Obstet Gynecol Scand Suppl; 1982 Nov 29; 111():1-60. PubMed ID: 6216716
    [No Abstract] [Full Text] [Related]

  • 7. [Side effects of oral contraceptives in the first treatment cycle].
    Feichtinger W, Babor P, Herczeg KM, Heyda M, Hoffmann R, Plöckinger B, Steinhauser B.
    Wien Med Wochenschr; 1991 Nov 29; 141(18-19):412-5. PubMed ID: 1837965
    [Abstract] [Full Text] [Related]

  • 8. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
    Bilotta P, Favilli S.
    Minerva Ginecol; 1987 Dec 29; 39(12):855-69. PubMed ID: 3329705
    [No Abstract] [Full Text] [Related]

  • 9. [Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception].
    Galán G, Gayán P, Tisné L.
    Rev Chil Obstet Ginecol; 1985 Dec 29; 50(4):317-24. PubMed ID: 2953049
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [New forms of hormonal contraception].
    Gaspard U, Buicu C, van den Brûle F.
    J Gynecol Obstet Biol Reprod (Paris); 2000 May 29; 29(3):288-91. PubMed ID: 10804374
    [Abstract] [Full Text] [Related]

  • 12. [Clinical study of a low-dose contraceptive--Femodene].
    Rachev E, Damianov L, Dukovski A, Katsarova M.
    Akush Ginekol (Sofiia); 1995 May 29; 34(3):71-3. PubMed ID: 8787249
    [Abstract] [Full Text] [Related]

  • 13. Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
    Weijers MJ.
    Clin Ther; 1982 May 29; 4(5):359-66. PubMed ID: 6461412
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical study of a monophasic pill containing 20 microg ethinylestradiol and 150 microg desogestrel in Thai women.
    Jaisamrarn U, Reinprayoon D, Virutamasen P.
    J Med Assoc Thai; 2001 Jun 29; 84 Suppl 1():S377-83. PubMed ID: 11529361
    [Abstract] [Full Text] [Related]

  • 16. Effects of a monophasic pill containing 20 microg ethinylestradiol and 150 microg desogestrel on lipid metabolism in Thai women.
    Jaisamrarn U, Taneepanichskul S, Wongwathanavikromn R, Reinprayoon D.
    J Med Assoc Thai; 2002 Jun 29; 85 Suppl 1():S429-34. PubMed ID: 12188447
    [Abstract] [Full Text] [Related]

  • 17. [A combiphasic oral contraceptive containing ethinylestradiol and desogestrel].
    Poulsen HK.
    Ugeskr Laeger; 1995 Aug 07; 157(32):4473-5. PubMed ID: 7483033
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
    Uchikova E, Batashki I, Milchev N, Mateva N, Markova D, Gŭrova A.
    Akush Ginekol (Sofiia); 2006 Aug 07; 45(2):39-43. PubMed ID: 16637303
    [Abstract] [Full Text] [Related]

  • 19. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug 07; 13(72):123-6. PubMed ID: 15532134
    [Abstract] [Full Text] [Related]

  • 20. [Effect and control of oral contraceptive Minesse (15 mkg EE/60 mkg Gestoden) on menstrual cycle and body weight].
    Krŭsteva.
    Akush Ginekol (Sofiia); 2003 Aug 07; 42(5):46-8. PubMed ID: 14682015
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.